Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -102,050 | -28,054 | -13,434 | -53,117 | -40,636 |
| Depreciation Amortization | 453 | 296 | 140 | 575 | 412 |
| Accounts receivable | -1,577 | 404 | 1,009 | -1,845 | -1,002 |
| Accounts payable and accrued liabilities | 219 | 234 | 152 | -3,709 | -3,148 |
| Other Working Capital | 5,859 | 5,184 | 2,565 | -4,291 | -4,218 |
| Other Operating Activity | 67,850 | 3,617 | -664 | 12,930 | 10,954 |
| Operating Cash Flow | $-29,246 | $-18,319 | $-10,232 | $-49,457 | $-37,638 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -184 | -77 | -10 | -459 | -545 |
| Investing Cash Flow | $-184 | $-77 | $-10 | $-459 | $-545 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -5,408 | N/A |
| Common Stock Issued | 56,490 | 600 | N/A | 240 | 240 |
| Common Stock Repurchased | -370 | -370 | N/A | -1,622 | -1,275 |
| Other Financing Activity | 0 | 0 | 0 | 47,101 | 0 |
| Financing Cash Flow | $56,120 | $230 | $N/A | $40,311 | $-1,035 |
| Beginning Cash Position | 61,729 | 61,729 | 61,729 | 71,334 | 71,335 |
| End Cash Position | 88,419 | 43,563 | 51,487 | 61,729 | 32,117 |
| Net Cash Flow | $26,690 | $-18,166 | $-10,242 | $-9,605 | $-39,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,246 | -18,319 | -10,232 | -49,457 | -37,638 |
| Capital Expenditure | -184 | -77 | -10 | -459 | -545 |
| Free Cash Flow | -29,430 | -18,396 | -10,242 | -49,916 | -38,183 |